proinflammatory mediator
[용어속성] Term
Coagulation Disorders and Thrombosis in COVID-19 Patients and a Possible Mechanism Involving Endothelial Cells: A Review
Review
[키워드] addition
adhesion molecules
Adults
affected
angiotensin-converting enzyme 2
antibody
Blood
Cell
cell activation
changes in
characterized
circulation
Coagulation
coagulation disorder
Coagulopathy
contribute
Coronavirus disease 2019
COVID-19
COVID-19 infection
COVID-19 patient
COVID-19 patients
Critical case
D-dimer
death
disease
disorder
dysfunction
elevated
endothelial cells
Endothelium
Evidence
Express
higher risk
increased risk
Inflammation
Involving
laboratory abnormalities
mechanism
Mortality
nitric oxide
Older
organ dysfunction
outcome
pandemic
pathophysiological
Platelet
predict
proinflammatory mediator
Prothrombin time
released
Research
review
SARS-CoV-2
severe cases
subendothelial
thrombosis
tissue
upregulation
virus
[DOI] 10.14336/AD.2021.0704 PMC 바로가기 [Article Type] Review
[DOI] 10.14336/AD.2021.0704 PMC 바로가기 [Article Type] Review
Covid-19 and oral diseases: Crosstalk, synergy or association?
코로나19와 구강질환: 누화, 시너지, 연관성?
Review
[키워드] acute respiratory syndrome
acute respiratory syndrome coronavirus
acute respiratory syndrome coronavirus 2
addition
Affect
alterations
angiotensin
angiotensin-converting enzyme 2
association
Bacterial
Blister
can not
caused
clinically
cohort study
coronavirus
coronavirus disease
Coronavirus disease 2019
COVID-19
COVID-19 patients
Crosstalk
Cytokines
destruction
disease
Diseases
dysfunction
elevated
Endothelial cell
endothelial cells
Endotheliitis
erythematous
Evidence
exacerbating
exhibit
Express
facilitate
Gingiva
gingivitis
growth
Gustatory
Health
human body
hyperinflammation
Immune-mediated
impair
Infection
Infectious disease
Inflammation
Interaction
lesion
lesions
Loss of Smell
loss of smell and taste
manifestation
mechanism
Multiple
multiple organ
multiple organs
necrotic
negative and positive
oral cavity
oral diseases.
oral health
oral infection
oral manifestation
oral tissue
Pathogenesis
Pathogens
pathway
Patient
plaque
plaques
proinflammatory mediator
proinflammatory mediators
promote inflammation
recent
receptor
reported
salivary
salivary gland
SARS-CoV-2
severe acute respiratory syndrome Coronavirus
Signs and symptoms
subject
subjects
Symptom
synergy
Taste
tissue homeostasis
tissue inflammation
viral entry
viral infection
viral replication
virus
virus spread
[DOI] 10.1002/rmv.2226 PMC 바로가기 [Article Type] Review
[DOI] 10.1002/rmv.2226 PMC 바로가기 [Article Type] Review
Profile of Circulatory Cytokines and Chemokines in Human Coronaviruses: A Systematic Review and Meta-Analysis
Immunology
[키워드] 95% confidence interval
activated
articles
CCL2/MCP-1
Characteristics
circulating
Circulatory
Clinical features
Cochrane Library
coronavirus disease
coronavirus diseases
coronavirus strain
coronavirus strains
COVID-19
COVID-19 patient
Cytokine storm
database
elevated
evaluate
Genetic
highlight
homology
Human
IL-10
IL-6
IL-8
Immune cell
immune response
immunopathology
IMPROVE
Increased
inflammatory biomarkers
Inflammatory cytokine
inflammatory cytokine profile
Inflammatory cytokines
MERS
MERS-CoV
Meta-analysis
observational study
outcome
phenotype
potential therapeutic target
profile
proinflammatory mediator
random-effects model
Registration
Result
review
SARS
SARS-CoV
SARS-CoV-2
screened
searched
Severe case
severe cases
severity
severity of COVID-19
Severity of infection
strain
systematic review
TNF
was performed
[DOI] 10.3389/fimmu.2021.666223 PMC 바로가기 [Article Type] Immunology
[DOI] 10.3389/fimmu.2021.666223 PMC 바로가기 [Article Type] Immunology
Galectin-9, a Player in Cytokine Release Syndrome and a Surrogate Diagnostic Biomarker in SARS-CoV-2 Infection
갈렉틴-9, 사이토카인 방출 증후군의 플레이어이자 SARS-CoV-2 감염의 대리 진단 바이오마커
Comparative Study
[키워드] activated
Alpha
baseline
Biomarker
C-reactive protein
C-reactive protein (CRP
characteristic
chemokine
chemokines
clinical
clinical evidence
correlation
COVID-19
COVID-19 infection
COVID-19 patient
COVID-19 patients
cytokine
Cytokine release syndrome
Cytokine storm
Cytokines
diagnostic
downregulation
Evidence
expression
Galectin-9
growth factor
HCs
healthy control
healthy controls
IL-6
immune activation
impacted
implicated
in vitro
indicated
individual
interleukin
interleukin-6
inverse correlation
IP-10
MCP-1
MIP-1α
monocyte
Monocytes
Mortality
Necrosis
neutrophil
Neutrophils
NK cell
NK cells
outbreak
phenotype
plasma
positive correlation
proinflammatory
proinflammatory cytokines
proinflammatory mediator
proinflammatory mediators
receiver operating characteristic
Release
ROC
SARS-CoV-2
SARS-COV-2 infection
surrogate
TGF-β
Therapeutic approach
TNF-α
transforming growth factor
treated
Tumor
tumor necrosis
tumor necrosis factor
tumor necrosis factor alpha
[DOI] 10.1128/mBio.00384-21 PMC 바로가기 [Article Type] Comparative Study
[DOI] 10.1128/mBio.00384-21 PMC 바로가기 [Article Type] Comparative Study
SARS-CoV-2: Immune Response Elicited by Infection and Development of Vaccines and Treatments
SARS-CoV-2: 감염 및 백신 및 치료제 개발로 유발되는 면역 반응
Review
[키워드] acute respiratory syndrome coronavirus
addition
administration
affected
antiparasitic
antivirals
approach
approved
caused
characterized
clinical
clinical evidence
clinical manifestation
clinical manifestations
Clinical stages
clinical trial
clinical trials
contribute
convalescent serum
coronavirus
coronavirus 2
coronavirus disease
COVID-19
COVID-19 disease
current therapy
deaths
described
development
disease
distress
drug
dry cough
effective
Evidence
exacerbated
FDA
Fever
food
Food and Drug Administration
headache
Health Organization
Human
Hydroxychloroquine
immune
Immune cell
immune cells
immune response
immunological
imperative
Infection
Infectious disease
information
mediators
Migration
monoclonal antibody
monoclonal antibody therapy
neutralize
organ
pandemic
Phase III clinical trials
potential therapy
Prevent
proinflammatory mediator
proinflammatory mediators
respiratory
respiratory distress
response
SARS-CoV-2
SARS-CoV-2 patients
severe acute respiratory syndrome Coronavirus
severe acute respiratory syndrome coronavirus 2
Severe case
severe cases
Symptom
tested
therapy
Treatment
treatments
Vaccine
vaccine candidate
Vaccines
virus
WHO
World Health Organization
[DOI] 10.3389/fimmu.2020.569760 PMC 바로가기 [Article Type] Review
[DOI] 10.3389/fimmu.2020.569760 PMC 바로가기 [Article Type] Review
Taming the cytokine storm: repurposing montelukast for the attenuation and prophylaxis of severe COVID-19 symptoms
사이토카인 폭풍 길들이기: 심각한 COVID-19 증상의 약화 및 예방을 위한 몬테루카스트 용도 변경
Article
[키워드] activated
acute respiratory syndrome
acute respiratory syndrome coronavirus
acute respiratory syndrome coronavirus 2
approved
Asthma
attenuation
characterized
clinical complication
Clinical outcome
clinical outcomes
coronavirus
COVID-19
cytokine
cytokine production
cytokine profile
Cytokine storm
decrease
Hyperinflammatory
immune response
infections
Inflammation
involved
mediators
modulate
Montelukast
NF-κB
NF-κB activation
nuclear
Patient
proinflammatory mediator
proinflammatory mediators
Prophylaxis
protein complex
reduction in
respiratory
SARS-CoV-2
severe acute respiratory syndrome Coronavirus
severe COVID-19 symptom
suppress
symptom severity
Viral
viral infections
[DOI] 10.1016/j.drudis.2020.09.013 PMC 바로가기 [Article Type] Article
[DOI] 10.1016/j.drudis.2020.09.013 PMC 바로가기 [Article Type] Article